Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device

Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina. This...

Will People Accept Rampant Inflation? Hell, No!

The Weekly Missive, which usually arrives over the weekend (sometimes on Friday, sometimes on Sunday) was delayed this weekend for one reason: I had to change it. I started out last week with an idea that was leaning in the direction of full-on capitulation in the sen...

Buzz on the Bullboards: The Top Last-Minute Movers of 2021

Expecting the markets to be relaxed heading into the holidays? Hardly. Many investors and brokers know that this is the time to shine. With every twist and turn the global economy has been throwing our way, the right move is staying active. This past week, it seems ma...

Disrupting the Cannabinoid Industry with Science and Innovation

(Click image to play video) Get to know Toronto-based Avicanna Inc. (AVCN) ( TSX.AVCN , OTC: AVCNF , Forum ) – a biopharmaceutical company developing and driving biopharmaceutical advancements of plant-derived cannabinoid-based products, and the man at the h...

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results

Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. Clinical-...

Rising Star Trillion Energy Ready to Supply Much Needed European Gas

Trillion Energy (CSE:TCF) is a company poised to bring on desperately needed natural gas production within weeks to the European market.

SunPower (SPWRA): Retreating into familiar territory

Last week, SunPower Corporation ( NASDAQ: SPWRA , Stock Forum ) updated its 2011 guidance, predicting that ex-items earnings per share would range between $1.75 and $2.05. Revenue for the upcoming fiscal year is predicted to arrive between $2.65 billion and $2.85 billion....

Cummins (CMI): Bullish bandwagon far from crowded

Engine issue Cummins Inc. ( NYSE: CMI , Stock Forum ) has been a broad-market standout, to say the least, besting its fellow S&P 500 Index (SPX) comrades with a gain of roughly 140% in 2010. What’s more, the equity has outperformed the SPX by almost 12% du...

Chesapeake Energy (CHK): Can its stock continue to make new highs?

Chesapeake Energy Corp. ( NYSE: CHK , Stock Forum ) has embarked on a quest for new multi-year highs this week, after last night announcing a deal with CNOOC Ltd. ( NYSE: CEO , Stock Forum ). More specifically, the China-based firm said it will buy into several of Chesape...
1 2 3 4 5 6 7 8 9 10 ...